重视慢性肝病的病情评估

doi:10.3969/j.issn.1672-5069.2017.01.002

实用肝脏病杂志 ›› 2017, Vol. 20 ›› Issue (1): 4-6.doi: 10.3969/j.issn.1672-5069.2017.01.002

重视慢性肝病的病情评估

陈柳莹, 陆伦根

200080 上海市上海交通大学附属第一人民医院消化科

收稿日期:2016-11-08 出版日期:2017-01-20 发布日期:2017-02-10
通讯作者: 陆伦根,E-mail:lungenlu1965@163.com
作者简介:陈柳莹,女,26岁,博士研究生

Evaluation of chronic liver diseases

Chen Liuying, Lu Lungen.

Department of Gastroenterology,First People’s Hospital,Affiliated to Jiaotong University,Shanghai 200080

Received:2016-11-08 Online:2017-01-20 Published:2017-02-10

摘要/Abstract

摘要：

关键词: 慢性肝病, 病情, 评估

Key words: Chronic liver diseases, Severity, Evaluation

陈柳莹, 陆伦根. 重视慢性肝病的病情评估[J]. 实用肝脏病杂志, 2017, 20(1): 4-6.

Chen Liuying, Lu Lungen.. Evaluation of chronic liver diseases[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 4-6.

[1] Wang Y,Hou JL. Current strategies for quantitating fibrosis in liver biopsy. Chin Med J,2015,128（2）:252-258.
[2] Castéra L,Vergniol J,Foucher J,et al. Prospective comparison of transient elastography,fibrotest,APRI,and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology,2005,128（2）:343-350.
[3] Foucher J,Chanteloup E,Vergniol J,et al. Diagnosis of cirrhosis by transient elastography （FibroScan）:a prospective study. Gut,2006,55（3）:403-408.
[4] Nierhoff J,Chavez Ortiz AA,Herrmann E,et al. The efficiency of acoustic radiation force impulse imaging for the staging of liver fibrosis:a meta-analysis. Eur Radiol,2013,23（11）:3040-3053.
[5] Ichikawa S,Motosugi U,Ichikawa T,et al. Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C. Magnet Reson Med Sci,2012,11（4）:291-297.
[6] Chen J,Talwalkar J A,Yin M,et al. Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology,2011,259（3）: 749-756.
[7] Motosugi U,Ichikawa T,Sano K,et al. Magnetic resonance elastography of the liver:preliminary results and estimation of inter-rater reliability. Jap J Radiol,2010,28（8）:623-627.
[8] Jarcuska P,Janicko M,Veseliny E,et al. Circulating markers of liver fibrosis progression. Clinica Chim Acta,2010,411（15-16）: 1009-1017.
[9] Qi X,Liu X,Zhang Y,et al. Serum liver fibrosis markers in the prognosis of liver cirrhosis:A prospective observational study. Med Sci Moni,2016,22:2720-2730.
[10] Seki E,Schwabe R F. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology （Baltimore,Md）, 2015,61（3）:1066-1079.
[11] Corpechot C,Barbu V,Wendum D,et al. Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis. Hepatology （Baltimore, Md）,2002,35（5）:1010-1021.
[12] Tamimi TI,Elgouhari HM,Alkhouri N,et al. An apoptosis panel for nonalcoholic steatohepatitis diagnosis. J Hepatol,2011,54（6）:1224-1229.
[13] Bantel H,Lugering A,Heidemann J,et al. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology （Baltimore,Md）,2004,40（5）:1078-1087.
[14] Deng YQ,Zhao H,Ma AL,et al. Selected cytokines serve as potential biomarkers for predicting liver inflammation and fibrosis in chronic hepatitis B patients with normal to mildly elevated aminotransferases . Medicine,2015,94（45）:e2003.
[15] Kakumu S,Okumura A,Ishikawa T,et al. Serum levels of IL-10,IL-15 and soluble tumour necrosis factor-alpha （TNF-
alpha） receptors in type C chronic liver disease. Clin Experiment Immunol,1997,109（3）:458-463.
[16] Bader El Din N G,Farouk S,El-Shenawy R,et al. Tumor necrosis factor-alpha-G308A polymorphism is associated with liver pathological changes in hepatitis C virus patients. World J Gastroenterol,2016,22（34）:7767-7777.
[17] Papatheodoridis G V,Hadziyannis E,Tsochatzis E,et al. Serum apoptotic caspase activity as a marker of severity in HBeAg-
negative chronic hepatitis B virus infection. Gut,2008,57（4）:500-506.
[18] Han L H,Sun W S,Ma C H,et al. Detection of soluble TRAIL in HBV infected patients and its clinical implications. World J Gastroenterol,2002,8（6）:1077-1080.
[19] Antoine D J,Dear J W,Lewis P S,et al. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology （Baltimore,Md）,2013,58（2）:777-787.
[20] Sharara A I,Rockey D C. Gastroesophageal variceal hemorrhage. New Engl J Med,2001,345（9）:669-681.
[21] Lee S W,Lee T Y,Chang C S. Independent factors associated with recurrent bleeding in cirrhotic patients with esophageal variceal hemorrhage. Dig Dis Sci,2009,54（5）:1128-1134.
[22] European Association for the Study of The L. EASL clinical practice guidelines on the management of ascites,spontaneous bacterial peritonitis,and hepatorenal syndrome in cirrhosis. J Hepatol,2010,53（3）:397-417.
[23] Piroth L,Pechinot A,Di Martino V,et al. Evolving epidemiology and antimicrobial resistance in spontaneous bacterial peritonitis:a two-year observational study. BMC Infect Dis,2014,14:287.
[24] Oliveira AM,Branco JC,Barosa R,et al. Clinical and microbiological characteristics associated with mortality in spontaneous bacterial peritonitis:a multicenter cohort study. Eur J Gastroenterol Hepatol,2016,28（10）:1216-1222.
[25] Nischalke HD,Berger C,Aldenhoff K,et al. Toll-like receptor （TLR） 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis. J Hepatol,2011,55（5）:1010-1016.
[26] Lutz P,Berger C,Langhans B,et al. A farnesoid X receptor polymorphism predisposes to spontaneous bacterial peritonitis. Dig Liver Dis,2014,46（11）1047-1050.

重视慢性肝病的病情评估

Evaluation of chronic liver diseases

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	武丹, 马向鹰. 非酒精性脂肪性肝病肝硬化患者胰岛素抵抗水平与颈动脉硬化程度和左心室功能研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 876-879.
[2]	巴正武, 栗海龙, 杨慧. 能谱CT成像定量评估Budd-Chiari综合征患者TIPS术治疗前后肝功能状态临床价值研究*[J]. 实用肝脏病杂志, 2019, 22(5): 680-683.
[3]	唐承薇. 慢性肝病与血小板减少：临床处理观念的转变[J]. 实用肝脏病杂志, 2019, 22(4): 457-458.
[4]	谢晓（综述）,陆伦根（审校）. 无创诊断和评估非酒精性脂肪性肝炎研究进展^*[J]. 实用肝脏病杂志, 2019, 22(2): 301-306.
[5]	张利宁, 刘志刚, 高彩霞, 白桂林, 张晓玲. 授权教育饮食干预在乙型肝炎相关性肾炎患者中的应用研究^*[J]. 实用肝脏病杂志, 2018, 21(5): 799-800.
[6]	石朋, 王坤, 沈俊春, 卢文波. CT检查在原发性肝癌患者经肝动脉化疗栓塞术后疗效评估中的应用价值分析[J]. 实用肝脏病杂志, 2018, 21(2): 253-256.
[7]	王艳欣综述, 于红卫, 朱跃科审校. 慢性肝病的营养评估与治疗*[J]. 实用肝脏病杂志, 2018, 21(2): 317-320.
[8]	栗雪峰, 李建生, 马金良, 荚卫东, 刘文斌, 陈浩. 吲哚青绿清除试验、SPECT和三维重建技术在原发性肝癌患者行半肝切除术中的应用^*[J]. 实用肝脏病杂志, 2017, 20(4): 477-480.
[9]	王治冲，宋风斌. 失代偿期乙型肝炎肝硬化患者营养状况分析[J]. 实用肝脏病杂志, 2017, 20(2): 236-237.
[10]	翁丽媚, 王炳元. 酒精性肝病的临床评估[J]. 实用肝脏病杂志, 2017, 20(1): 7-9.
[11]	程询, 杨长青. 检测门脉高压程度评估肝硬化严重程度研究进展[J]. 实用肝脏病杂志, 2017, 20(1): 10-12.
[12]	李爽, 陈煜. 急性肝衰竭病情严重程度评估[J]. 实用肝脏病杂志, 2017, 20(1): 17-20.
[13]	魏新朋，韩际奥，高晓，杨丽，马英杰. 肝硬化患者病情与小肠细菌过度生长变化关系探讨[J]. 实用肝脏病杂志, 2016, 19(3): 310-313.
[14]	马振增, 陆伦根. 非酒精性脂肪性肝病与肝硬化[J]. 实用肝脏病杂志, 2016, 19(2): 135-138.
[15]	曾静, 范建高. 脾脏硬度检测在慢性肝病无创诊断中的应用^*[J]. 实用肝脏病杂志, 2015, 18(2): 209-212.